ATC Group: G02CX02 Flibanserin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G02CX02 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G02 Other gynecologicals
3 G02C Other gynecologicals
4 G02CX Other gynecologicals
5 G02CX02

Active ingredients in G02CX02

Active Ingredient Description
Flibanserin

Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.

Related product monographs

Title Information Source Document Type  
ADDYI Film coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.